Live News Categoriesequity

Xbrane Biopharma AB (publ) (XBRANE.ST) News

Follow Xbrane Biopharma AB (publ) (XBRANE.ST) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol XBRANE.ST Asset equity Sector Markets 90 days 1 Last 12 Updated Oct 13, 2026, 06:05 AM UTC Open live news feed Open XBRANE.ST chart & news

L Xbrane Biopharma says Xdivane melanoma pivotal trial reaches full recruitment of about 340 patients Xbrane reported full recruitment in its pivotal clinical trial for Xdivane, a biosimilar candidate to Opdivo (nivolumab). No results have been presented; the program now moves toward generating data for future regulatory NEWS | Oct 13, 2026, 06:05 AM UTC